These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 26726800

  • 1. Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
    Kiiski HS, Ní Riada S, Lalor EC, Gonçalves NR, Nolan H, Whelan R, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, Ó Donnchadha S, Hutchinson M, Tubridy N, Reilly RB.
    PLoS One; 2016; 11(1):e0146084. PubMed ID: 26726800
    [Abstract] [Full Text] [Related]

  • 2. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB.
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [Abstract] [Full Text] [Related]

  • 3. Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a.
    Liscić RM, Brecelj J.
    Croat Med J; 2004 Jun; 45(3):323-7. PubMed ID: 15185427
    [Abstract] [Full Text] [Related]

  • 4. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
    Taş A, Cakir Gundogan F, Akgun H, Erdem U, Sobaci G.
    Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
    [Abstract] [Full Text] [Related]

  • 5. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A, Sebraoui H, Hess E, Wagner A, Then Bergh F.
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Visual Evoked Potentials in Patients Affected by Optic Neuritis From Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.
    Filgueiras TG, Oyamada MK, Hokazono K, Cunha LP, Apóstolos-Pereira SL, Callegaro D, Monteiro MLR.
    J Neuroophthalmol; 2022 Mar 01; 42(1):e32-e39. PubMed ID: 34348361
    [Abstract] [Full Text] [Related]

  • 7. An analysis of VEP components in optic neuritis.
    Andersson T, Sidén A.
    Electromyogr Clin Neurophysiol; 1995 Mar 01; 35(2):77-85. PubMed ID: 7781577
    [Abstract] [Full Text] [Related]

  • 8. Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Piedrabuena R, Bittar M.
    Mult Scler Relat Disord; 2022 Jan 01; 57():103420. PubMed ID: 34906813
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of axonal optic nerve damage using visual evoked potentials and optical coherence tomography in patients with multiple sclerosis.
    Pastare D, Kire I, Erts R, Laganovska G, Millers A.
    Medicina (Kaunas); 2013 Jan 01; 49(11):474-8. PubMed ID: 24823928
    [Abstract] [Full Text] [Related]

  • 10. Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus.
    Papadopoulou A, Pfister A, Tsagkas C, Gaetano L, Sellathurai S, D'Souza M, Cerdá-Fuertes N, Gugleta K, Descoteaux M, Chakravarty MM, Fuhr P, Kappos L, Granziera C, Magon S, Sprenger T, Hardmeier M.
    Clin Neurophysiol; 2024 May 01; 161():122-132. PubMed ID: 38461596
    [Abstract] [Full Text] [Related]

  • 11. VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis.
    Janáky M, Jánossy Á, Horváth G, Benedek G, Braunitzer G.
    Doc Ophthalmol; 2017 Jun 01; 134(3):185-193. PubMed ID: 28421377
    [Abstract] [Full Text] [Related]

  • 12. Impaired VEP after photostress response in multiple sclerosis patients previously affected by optic neuritis.
    Parisi V, Pierelli F, Restuccia R, Spadaro M, Parisi L, Colacino G, Bucci MG.
    Electroencephalogr Clin Neurophysiol; 1998 Jan 01; 108(1):73-9. PubMed ID: 9474064
    [Abstract] [Full Text] [Related]

  • 13. Analysis of multiple sclerosis patients with electrophysiological and structural tests.
    Hamurcu M, Orhan G, Sarıcaoğlu MS, Mungan S, Duru Z.
    Int Ophthalmol; 2017 Jun 01; 37(3):649-653. PubMed ID: 27538913
    [Abstract] [Full Text] [Related]

  • 14. Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
    Tugcu B, Soysal A, Kılıc M, Yuksel B, Kale N, Yıgıt U, Arpaci B.
    J Neurol Sci; 2013 Dec 15; 335(1-2):182-5. PubMed ID: 24148562
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
    Chatziralli IP, Moschos MM, Brouzas D, Kopsidas K, Ladas ID.
    Clin Exp Optom; 2012 Mar 15; 95(2):223-8. PubMed ID: 22329676
    [Abstract] [Full Text] [Related]

  • 16. Evolution of visual evoked potentials in optic neuritis.
    Heinrichs IH, McLean DR.
    Can J Neurol Sci; 1988 Nov 15; 15(4):394-6. PubMed ID: 3208223
    [Abstract] [Full Text] [Related]

  • 17. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis.
    Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP.
    Neuroradiology; 1998 Dec 15; 40(12):765-70. PubMed ID: 9877128
    [Abstract] [Full Text] [Related]

  • 18. Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
    Laron M, Cheng H, Zhang B, Schiffman JS, Tang RA, Frishman LJ.
    Mult Scler; 2009 Dec 15; 15(12):1431-41. PubMed ID: 19995841
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
    Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R, Centonze D.
    Mult Scler; 2014 Dec 15; 20(14):1841-50. PubMed ID: 24876157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.